Clinical Genomics is leading provider of cancer diagnostic solutions, offering COLVERA™, a new liquid biopsy test identifying ctDNA in patients post-treatment for early detection of CRC recurrence and post-surgery for detection of residual disease, and InSure® ONE™, a fecal immunochemical test used in screening programs for healthy adults. Clinical Genomics continues to apply its proprietary innovation in molecular pathology to commercialize other diagnostic tools in other cancer types.